Showing 1–16 of 18 results
MHP CELL-X Research Stack The MHP CELL-X Research Stack combines Sermorelin, MOTS-C, and NAD+ as three separate research materials for laboratory studies involving endocrine signaling, mitochondrial function, cellular metabolism, redox biology, cellular energy, and metabolic communication. This three-component research system gives researchers distinct approaches to cellular and metabolic investigation. Sermorelin is studied for GHRH receptor…
MHP SIGNAL-X™ Research Stack The MHP SIGNAL-X™ Research Stack combines Sermorelin and Ipamorelin as two separate research compounds for laboratory studies involving growth hormone signaling, pituitary signaling, GHRH receptor activity, ghrelin receptor activity, endocrine communication, and pulsatile signaling pathways. This combination gives researchers two different approaches to growth hormone-related signaling research: Sermorelin is studied for…
MK-677 (Ibutamoren) 10mg Research Capsules MK-677, also known as Ibutamoren, is a research compound commonly studied for its effects on growth hormone and IGF-1 signaling. Researchers are particularly interested in how these pathways relate to muscle and tissue growth, recovery, body composition, sleep, metabolism, and age-related changes in growth hormone signaling. MK-677 is not a…
MHP PERFORMANCE-X Research Stack The MHP PERFORMANCE-X Research Stack combines Tesamorelin, Ipamorelin, and MOTS-C as three separate research compounds for laboratory studies involving GHRH signaling, growth hormone secretagogue receptor signaling, mitochondrial function, cellular-energy regulation, metabolic signaling, and interactions between endocrine and mitochondrial pathways. Each research material represents a different area of investigation. Tesamorelin is studied…
MHP ENDURA-X PRO Research Stack The MHP ENDURA-X PRO Research Stack combines SLU-PP-332, MOTS-C, and SS-31 as three separate research compounds for controlled laboratory investigation of exercise-associated molecular signaling, mitochondrial function, cellular bioenergetics, oxidative-stress response pathways, and metabolic adaptation. The three research materials are investigated through distinct but related mechanisms. SLU-PP-332 is studied primarily for…
CJC-1295 No DAC 10mg Research Compound CJC-1295 No DAC is a research peptide studied for its interaction with growth hormone-releasing hormone (GHRH) receptors. These receptors help control the biological signals involved in growth hormone release and downstream IGF-1 signaling. Unlike CJC-1295 with DAC, this version does not contain the Drug Affinity Complex designed to extend…
CJC-1295 With DAC 10mg Research Compound CJC-1295 with DAC is a research peptide studied for its ability to activate growth hormone-releasing hormone (GHRH) receptors. These receptors are part of the biological signaling system that controls the release of growth hormone and influences downstream IGF-1 signaling. The DAC portion is what makes this version of CJC-1295…
MHP AXIS-X Research Stack The MHP AXIS-X Research Stack combines Tesamorelin and Ipamorelin as two separate research compounds for laboratory studies involving growth hormone-related signaling, GHRH receptor activity, growth hormone secretagogue receptor signaling, endocrine communication, metabolic pathways, and downstream cellular responses. The two compounds are investigated through different receptor systems. Tesamorelin is studied primarily for…
Ipamorelin and Tesamorelin are investigated in laboratory and preclinical research involving:
These areas represent subjects of laboratory and preclinical investigation
and do not indicate safety, effectiveness, therapeutic benefit, or
suitability for human use.
The Ipamorelin 5mg + Tesamorelin 5mg Research Blend
combines equal quantities of Ipamorelin and Tesamorelin in a single
10mg lyophilized research preparation.
Ipamorelin is investigated in experimental research
involving growth hormone secretagogue receptor activity and associated
growth hormone-related signaling mechanisms.
Tesamorelin is investigated in laboratory and preclinical
research involving growth hormone-releasing hormone (GHRH) receptor
signaling and associated downstream molecular and metabolic pathways.
Combining the two compounds in a defined research preparation allows
investigators to examine interactions between distinct growth
hormone-related signaling mechanisms within appropriately designed
experimental models.
Ipamorelin is studied in experimental models involving growth hormone
secretagogue receptor signaling and mechanisms associated with
growth hormone-related molecular responses.
Tesamorelin is studied in experimental models involving GHRH receptor
signaling and associated downstream growth hormone-related pathways.
The combined preparation may be incorporated into appropriately
designed experimental models examining interactions between
secretagogue-mediated and GHRH receptor-mediated signaling pathways.
Research observations may vary depending on methodology, handling,
storage conditions, experimental environment, and study design.
Research Use Only
This material is supplied strictly for laboratory research and
analytical applications. It is not intended for human consumption
or for medical, cosmetic, veterinary, or therapeutic use.
Mile High Peptides LLC supplies this material strictly for analytical
and in-vitro laboratory research applications by qualified research
professionals.
AOD-9604 + Tesamorelin + MOTS-C 15 mg Research Blend This three-component research blend combines AOD-9604, Tesamorelin, and MOTS-C in a single lyophilized preparation for controlled laboratory investigation of metabolic signaling, growth hormone-related pathways, mitochondrial processes, cellular energy regulation, and associated molecular mechanisms. Blend Composition AOD-9604: 5 mg Tesamorelin: 5 mg MOTS-C: 5 mg Total research…
CJC-1295 (No DAC) + Ipamorelin 10 mg / 20 mg Research Blend CJC-1295 (No DAC) + Ipamorelin is a two-compound research blend investigated in laboratory and preclinical models involving growth hormone-related signaling, growth hormone-releasing hormone (GHRH) pathways, growth hormone secretagogue receptor activity, and downstream cellular and metabolic responses. Research Areas of Interest Growth hormone-related signaling…
GHRP-6 10 mg Research Peptide GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic research peptide investigated in laboratory and preclinical models involving growth hormone secretagogue receptor signaling, growth hormone-related pathways, metabolic regulation, and appetite-associated signaling. Research Areas of Interest Growth hormone secretagogue receptor (GHSR) activity Growth hormone-related signaling pathways Pituitary signaling research Ghrelin-associated signaling pathways Appetite…
IGF-1 LR3 0.1 mg Research Compound IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a modified analog of IGF-1 investigated in laboratory research involving IGF receptor signaling, cellular growth pathways, protein synthesis, and tissue-response mechanisms. Research Areas of Interest IGF-1 receptor (IGF-1R) signaling Cellular growth and proliferation pathways Protein-synthesis signaling Muscle and skeletal-tissue research models…
Ipamorelin | Laboratory Research Compound | Mile High Peptides LLC Ipamorelin is a synthetic research peptide investigated in controlled laboratory models involving growth hormone-related signaling, growth hormone secretagogue receptor activity, endocrine pathways, and associated metabolic responses. Commonly Researched For Growth hormone-related signaling pathways Growth hormone secretagogue receptor activity Endocrine signaling and cellular-response mechanisms Metabolic signaling…
Sermorelin Research Peptide Sermorelin is a synthetic peptide fragment corresponding to the first 29 amino acids of growth hormone-releasing hormone (GHRH). It is investigated in controlled laboratory models involving GHRH receptor signaling, pituitary-associated signaling pathways, growth hormone-related responses, and downstream molecular mechanisms. Research Areas of Interest Growth hormone-releasing hormone (GHRH) receptor signaling Pituitary-associated signaling pathways…
SLU-PP-332 500 mcg Research Capsules SLU-PP-332 is a small-molecule research compound investigated in controlled laboratory models involving estrogen-related receptor (ERR) signaling, mitochondrial processes, oxidative metabolism, cellular energy regulation, and exercise-associated molecular pathways. This product contains 500 mcg of SLU-PP-332 per capsule in a 100-count research format. Research Areas of Interest Estrogen-related receptor (ERR) signaling pathways…
Search the complete catalog or continue browsing.
Can't find what you are looking for? Reach out to us!
You must be 21 or older to enter this site.
